Alembic Pharmaceuticals Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

09:15 AM, 15th Nov 2025

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP 30 mg 60 mg 90 mg and 120 mg